Journal Article10.1126/SCIENCE.1164022
Astroglial metabolic networks sustain hippocampal synaptic transmission.
Nathalie Rouach,Annette Koulakoff,Veronica Abudara,Veronica Abudara,Klaus Willecke,Christian Giaume +5 more
TL;DR: It is shown that the gap-junction subunit proteins connexin 43 and 30 allow intercellular trafficking of glucose and its metabolites through astroglial networks for the delivery of energetic metabolites from blood vessels to distal neurons.
read more
Abstract: Astrocytes provide metabolic substrates to neurons in an activity-dependent manner. However, the molecular mechanisms involved in this function, as well as its role in synaptic transmission, remain unclear. Here, we show that the gap-junction subunit proteins connexin 43 and 30 allow intercellular trafficking of glucose and its metabolites through astroglial networks. This trafficking is regulated by glutamatergic synaptic activity mediated by AMPA receptors. In the absence of extracellular glucose, the delivery of glucose or lactate to astrocytes sustains glutamatergic synaptic transmission and epileptiform activity only when they are connected by gap junctions. These results indicate that astroglial gap junctions provide an activity-dependent intercellular pathway for the delivery of energetic metabolites from blood vessels to distal neurons.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Astrocytes: biology and pathology
TL;DR: Astrocyte functions in healthy CNS, mechanisms and functions of reactive astrogliosis and glial scar formation, and ways in which reactive astrocytes may cause or contribute to specific CNS disorders and lesions are reviewed.
Molecular dissection of reactive astrogliosis and glial scar formation.
TL;DR: Developments in the signaling mechanisms that regulate specific aspects of reactive astrogliosis are reviewed and the potential to identify novel therapeutic molecular targets for diverse neurological disorders is highlighted.
2.5K
Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation
TL;DR: This review focuses on the cellular aspects of brain energy metabolism, with a particular emphasis on the metabolic interactions between neurons and astrocytes.
2K
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng,Paul Edison +1 more
TL;DR: The interrelationships between Neuroinflammation and amyloid and tau pathologies as well as the effect of neuroinflammation on the disease trajectory in AD are discussed, focusing on microglia as major players in neuro inflammation and how these cells could be modulated as a therapeutic strategy for AD.
1.9K
Synaptic Energy Use and Supply
TL;DR: This work describes how information transmission through presynaptic terminals and postsynaptic spines is related to their energy consumption, and assess which mechanisms normally ensure an adequate supply of ATP to these structures.
1.5K
References
Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization
TL;DR: It is reported that glutamate, in addition to its receptor-mediated actions on neuronal excitability, stimulates glycolysis--i.e., glucose utilization and lactate production--in astrocytes and is consistent with data obtained from functional brain imaging studies indicating local nonoxidative glucose utilization during physiological activation.
2.8K
Metabolic coupling between glia and neurons
TL;DR: The aim of this review was to establish a chronology of events leading to and following the publication of the LNDC-REVIEW in 1996.
1K
Signaling at the Gliovascular Interface
TL;DR: Astrocytic end-foot processes plastered at the vessel wall as a center for purinergic signaling is identified, speculated that calcium signaling may play a role in astrocyic functions related to the blood-brain barrier, including blood flow regulation, metabolic trafficking, and water homeostasis.
605
2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP–dependent metabolic regulation of chromatin structure
Mireia Garriga-Canut,Barry Schoenike,Romena Qazi,Karen Bergendahl,Timothy J Daley,Rebecca M Pfender,John F Morrison,Jeffrey C. Ockuly,Carl E. Stafstrom,Thomas P. Sutula,Avtar Roopra +10 more
TL;DR: 2DG potently reduces the progression of kindling and blocks seizure-induced increases in the expression of brain-derived neurotrophic factor and its receptor, TrkB, suggesting that anti-glycolytic compounds may represent a new class of drugs for treating epilepsy.
471
Segregated expression of AMPA-type glutamate receptors and glutamate transporters defines distinct astrocyte populations in the mouse hippocampus.
Katja Matthias,Frank Kirchhoff,Gerald Seifert,Kerstin Hüttmann,Marina Matyash,Helmut Kettenmann,Christian Steinhäuser +6 more
TL;DR: The observed heterogeneity of cells with GFAP promoter-regulated EGFP expression and S100β/GFAP immunoreactivity challenges the hitherto accepted definition of astrocytes.
464